Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: The Kuopio Ischaemic Heart Disease Risk Factor Study

Archives of Internal Medicine

Volumn 160, Issue 8, 2000, Pages 1160-1168

  Lakka, Hanna Maaria ^a,c   Lakka, Timo A ^a   Tuomilehto, Jaakko ^b   Sivenius, Juhani ^a   Salonen, Jukka T ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; HYPERINSULINEMIA; HYPERTENSION; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

EID: 0034709065     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.8.1160     Document Type: Article

References (62)

1. Stern MP. The insulin resistance syndrome: the controversy is dead, long live the controversy! Diabetologia. 1994;37:956-958.
2. Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care. 1995;18:1299-1304.
3. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two studies in Finland. Diabetes Care. 1979;2:131-141.
4. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980; 19:205-210.
5. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
6. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation. 1998;98:398-404.
7. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991;34:355-361.
8. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia. 13-year study. J Chronic Dis. 1983;36:371-377.
9. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
10. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol. 1996;144:224-234.
11. Liu QZ, Knowler WC, Nelson RG, et al. Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians: cross-sectional and prospective analyses. Diabetes. 1992;41:1141-1150.
12. Rewers M, Shetterly SM, Baxter J, Hamman RF. Insulin and cardiovascular disease in Hispanics and non-Hispanic whites (NHW): the San Luis Valley Diabetes Study [abstract]. Circulation 1992;85:865.
13. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia. 1992;35:766-770.
14. Ferrara A, Barrett-Connor E, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study. 1984 to 1991. Am J Epidemiol. 1994;140:857-869.
15. Orchard TJ, Eichner J, Kuller LH, Becker DJ, McCallum LM, Grandits GA. Insulin as a predictor of coronary heart disease: interaction with apo E phenotype: a report from MRFIT. Ann Epidemiol. 1994;4:40-45.
16. Yarnell JWG, Sweetnam PM, Marks V, Teale JD, Bolton CH. Insulin in ischemic heart disease: are associations explained by triglyceride concentrations? the Caerphilly Prospective Study. Br Heart J. 1994;71:293-296.
17. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995;91:831-837.
18. Tuomilehto J, Tamosiunas A, Dowse G, et al. Hyperinsulinemia does not explain the high risk o1 cardiovascular disease in Mauritius [abstract]. Diabetologia. 1996; 39(suppl 1):A68.
19. Lakka TA, Lakka H-M, Salonen JT. Hyperinsulinemia and the risk of coronary heart disease. N Engl J Med. 1996;335:976-977.
20. Lindberg O, Tilvis RS, Strandberg TE, et al. Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc. 1997;45:407-412.
21. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Ekfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1997;20: 935-942.
22. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97: 996-1001.
23. Pyöralä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke. 1998;29:1860-1866.
24. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157-1164.
25. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-1607.
26. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X), Diabetes. 1992;41:715-722.
27. Mykkänen L, Kuusisto J, Haffner SM, Pyörälä K, Laakso M. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb. 1994;14:518-526.
28. Salonen JT, Lakka TA, Lakka H-M, Valkonen V-P, Everson SA, Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes. 1998;47:270-275.
29. Odeleye OE, de Courten M, Pettitt DJ, Ravussin E. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes. 1997;46:1341-1345.
30. Lazarus R, Sparrow D, Weiss S. Temporal relations between obesity and insulin: longitudinal data from the Normative Aging Study. Am J Epidemiol. 1998; 147:173-179.
31. Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality: the Paris Prospective Study. Arterioscler Thromb. 1992;12:1387-1392.
32. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Disease. Cambridge, Mass: Harvard University Press; 1980.
33. 125I-(Tyr A19)-insulin. Diabetologia. 1980;19:546-554.
34. 3 subfractions, and the risk of acute myocardial infarction: a prospective population study in eastern Finnish men. Circulation. 1991;84:129-139.
35. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803-811.
36. Lynch J, Helmrich SP, Lakka TA, et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med. 1996;156: 1307-1314.
37. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med. 1994;330:1549-1554.
38. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization: 1977.
39. Tuomilehto J, Arstila M, Kaarsalo E, et al. Acute myocardial infarction (AMI) in Finland: baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J. 1992;13:577-587
40. Tuomilehto J, Sarti C, Narva EV, et al. The FINMONICA stroke register: community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. Am J Epidemiol. 1992;135:1259-1270.
41. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187-201.
42. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol. 1996; 7:217-226.
43. Shinozaki K, Naritomi H, Shimizu T, et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke. 1996;27: 37-43.
44. Burchfiel CM, Sharp DS, Curb JD, et al. Hyperinsulinemia and cardiovascular disease in elderly men: the Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1998;3:450-457.
45. Nelson RG, Sievers ML, Knowler WC, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation. 1990;81:987-995.
46. Collins VR, Dowse GK, Zimmet PZ, et al. Serum insulin and ECG abnormalities suggesting coronary heart disease in the populations of Mauritius and Nauru: cross-sectional and longitudinal association. J Clin Epidemiol. 1993;46:1373-1393.
47. Laakso M, Pyörälä K, Voutilainen E, Marniemi J. Plasma insulin, serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol. 1987;125:611-621.
48. Burchfiel CM, Curb JD, Sharp DS, et al. Distribution and correlates of insulin in elderly men: the Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1995; 15:2213-2221.
49. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
50. Davidson MB. Clinical implications of insulin resistance syndromes. Am J Med. 1995;99:420-426.
51. Feskens EJM, Tuomilehto J, Stengård JH, Pekkanen J, Nissinen A, Kromhout D. Hypertension and overweight associated with hyperinsulinemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia. 1995;38:839-847.
52. Stout RW. Insulin and atherorna: 20-yr perspective. Diabetes Care. 1990;13: 631-654.
53. Laakso M, Sarlund H, Salonen R, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
54. Suzuki M, Shinozaki K, Kanazawa A, et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension. 1996;28:593-598.
55. Agewall S, Fagerbeig B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand A. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
56. Folsom AR, Eckfeldt JH, Weitzman S, et al. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;25:66-73.
57. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study. Circulation. 1995;91:1432-1443.
58. Haffner S. The insulin resistance syndrome revisited. Diabetes Care. 1996;19: 275-277.
59. Katz RJ, Ratner RE, Cohen RM, Elsenhower E, Verme D. Are insulin and proinsulin independent risk markers for premature coronary artery disease? Diabetes. 1996;45:736-741.
60. Yoshioka N, Kuzuya T, Matzuda A, Taniguchi M, Iwamoto Y. Serum proinsulin level at tasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1988;31:355-360.
61. Ward WK, LaCava EC, Raquette TL, Beard JC, Wallum BJ, Porte D Jr. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia. 1987;30: 698-702.
62. Temple RC, Clark PMS, Nagi DK, Schneider AE, Yudkm JS, Hales CN. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol (Oxf). 1990;32:689-693.